The CLM-group vs. NCLM:
• was admitted to hospital more often within 30 days because of CT (52% vs. 29%) • lacked a documented cessation decision more often (79% vs. 30%) • had a shorter survival from CT start to death (median-time 111 days vs. 288 days ) • died less often at home (24% vs. 38%) There were no differences between the groups in gender, age, diagnosis, and number of treatments.
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Background
Use of palliative chemotherapy treatment (CT) in incurable cancer has increased due to more available drugs and wider indications. Prolongation of life is successful in many cases. When to cease further CT is a difficult decision. To benefit from the very last CT a reasonable survival-time between last treatment and death ought to be at least one month.
Aim
The aim of this study was to identify the proportion of patients in 2008 who were being treated with palliative CT during their last month of life. 
Method

